MDK(SH:688079)2021-10-28 16:00Financial Performance - Q3 2021 revenue was CNY 109,620,351.10, a decrease of 0.42% year-over-year[5] - Net profit attributable to shareholders decreased by 39.71% to CNY 23,687,495.70 in Q3 2021[5] - The company reported a net profit decrease of 34.87% for the year-to-date period compared to the same period last year[10] - The net profit for Q3 2021 was CNY 71,311,580.67, a decrease of 33.5% compared to CNY 107,196,345.64 in Q3 2020[24] - The company reported a total comprehensive income of CNY 71,288,377.75 for Q3 2021, down from CNY 107,220,516.37 in Q3 2020, indicating a decline of 33.5%[25] Earnings and Shares - Basic earnings per share decreased by 60.65% to CNY 0.06 in Q3 2021[6] - Diluted earnings per share for the current period decreased by 60.65% year-on-year, primarily due to the increase in share capital from the initial public offering and a decline in net profit[11] - Year-to-date diluted earnings per share decreased by 47.83% year-on-year, reflecting similar factors as the current period[11] - Basic earnings per share for Q3 2021 were CNY 0.19, compared to CNY 0.36 in Q3 2020, representing a decrease of 47.2%[25] Research and Development - R&D expenses totaled CNY 16,443,464.00, an increase of 69.89% compared to the same period last year[6] - R&D expenses accounted for 15.00% of revenue, an increase of 6.21 percentage points year-over-year[6] - The company plans to strengthen R&D in new products and technologies, contributing to increased expenses[10] - Research and development expenses for the current period increased by 69.89% year-on-year, attributed to higher salaries for R&D personnel and the addition of multiple new R&D projects[11] - Year-to-date research and development expenses increased by 57.00% year-on-year, driven by salary increases and new R&D projects[11] Assets and Equity - Total assets increased by 69.29% to CNY 1,830,081,747.39 compared to the end of the previous year[6] - Shareholders' equity attributable to the parent company rose by 168.04% to CNY 1,550,638,445.82[6] - Total assets grew by 69.29% compared to the end of the previous year, mainly due to funds raised from the initial public offering[11] - Equity attributable to shareholders of the listed company increased by 168.04% compared to the end of the previous year, also due to funds raised from the initial public offering[11] Operating Revenue and Costs - Total operating revenue for the first three quarters of 2021 reached ¥318,113,602.93, a slight increase from ¥310,894,535.58 in the same period of 2020, representing a growth of approximately 0.7%[23] - Total operating costs for the first three quarters of 2021 were ¥239,948,201.47, up from ¥196,726,807.07 in 2020, indicating an increase of about 21.9%[23] - The total operating expenses for Q3 2021 were CNY 513,110,935.71, an increase from CNY 371,944,442.70 in Q3 2020, indicating a rise of 37.9%[29] Cash Flow and Investments - The cash flow from operating activities for Q3 2021 was CNY 144,176,438.28, up from CNY 118,027,630.27 in Q3 2020, reflecting a growth of 22.2%[29] - The company’s cash flow from financing activities for Q3 2021 was CNY 683,112,918.70, compared to CNY 203,936,872.17 in Q3 2020, reflecting an increase of 235.5%[30] - The company received CNY 962,434,840.29 from investment activities in Q3 2021, a significant increase from CNY 4,339,623.75 in Q3 2020[30] Inventory and Liabilities - Inventory levels increased to ¥74,684,466.81 from ¥54,884,372.02, reflecting a growth of about 36%[18] - The total liabilities decreased to ¥256,339,910.45 as of September 30, 2021, from ¥479,536,135.45 at the end of 2020, a reduction of approximately 46.6%[20] - Cash and cash equivalents rose significantly to ¥401,793,405.12 from ¥76,013,901.61, an increase of approximately 428%[18] - The cash and cash equivalents at the end of Q3 2021 amounted to CNY 401,793,405.12, significantly higher than CNY 39,085,940.69 at the end of Q3 2020, marking an increase of 927.5%[30]